Automated Drug Screening Platform Based on Molecular Dynamics and AI

Our AI engine predicts the drug potency based on our own data of binding affinities.

To develop an AI model for drug discovery, huge amount of receptor-ligand binding affinity data is needed, but currently reported experimental data is limited and small in number. Compared to most AI-based in-silico drug screening companies, we adopt bottom-up approach and generate data itself to train/improve AI engine using high-accuracy molecular dynamics.